(OTCQB:NBIO) ('Nascent Biotech', 'Nascent', or the 'Company'), a clinical-stage biotechnology Company pioneering the development of monoclonal ...
News
- Nascent Biotech Completes Third Cohort in Phase 1 Human Trial for Primary and Metastatic ...
- Oral pill improves care of patients with bone marrow cancer: Study - Medical Xpress
Ruben Mesa, MD, FACP, executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, presented results of ...
- Antibody therapies could penetrate pancreatic cancer's shield if research pays off
BiotechResearchmonoclonal antibodymonoclonal antibodies ... Ph.D., professor of obstetrics and gynecology at UT Health San Antonio and member of ...
- How will San Antonio's city council district map look after it is finalized? - Texas Public Radio
Redistricting committee finalized the map of San Antonio City Council ... Final draft map of all ten San Antonio City Council Districts.png.
- Plaque to basics: New research hints Alzheimer's treatments may be looking in the wrong place
... Ph.D., professor of obstetrics and gynecology at UT Health San Antonio ... The biotech aims to move the drugs into clinical trials early next ...